ArticleVaccine: X2024

SARS-CoV-2 vaccines in China could reduce COVID-19-related respiratory syndromes and deaths: A retrospective cohort study.

Weiping Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.